Prophylaxis of post-ERCP pancreatic complications with gabexate.
Piscaglia
F
F
Righini
R
R
Tewelde
A G
AG
D002760:Cholangiopancreatography, Endoscopic Retrograde / Q000009:adverse effects*; D002985:Clinical Protocols; D016670:Gabexate / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D010195:Pancreatitis / Q000517:prevention & control*; D012307:Risk Factors; D015842:Serine Proteinase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors
D015842:Serine Proteinase Inhibitors; D016670:Gabexate